²²⁵Ac-Labeled Somatostatin Analogs in the Management of Neuroendocrine Tumors: From Radiochemistry to Clinic

• Prif Awduron: Léa Rubira (Awdur), Emmanuel Deshayes (Awdur), Lore Santoro (Awdur), Pierre Olivier Kotzki (Awdur), Cyril Fersing (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: MDPI AG, 2023-03-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

The widespread use of peptide receptor radionuclide therapy (PRRT) represents a major therapeutic breakthrough in nuclear medicine, particularly since the introduction of ¹⁷⁷Lu-radiolabeled somatostatin analogs. These radiopharmaceuticals have especially improved progression-f...